Insilico Biotechnology designs and optimises biotechnological processes for the chemical and pharmaceutical industries. Successful in business since 2001, Insilico has internationally renowned expertise and a unique technology platform for connecting cell model libraries with simulation processes. Insilico analyses the latest biotech data und integrates it in genome-wide network models. With its high-performance computing techniques, Insilico develops new improved solutions for manufacturing biochemicals and biopharmaceuticals and achieves considerable cuts in the time needed for the development of bioprocesses. Insilico is a privately-owned company,
located in Stuttgart, Germany.
Further information on the websites of BIOPRO Baden-Württemberg: